Zobrazeno 1 - 10
of 2 732
pro vyhledávání: '"Echeverria, D"'
In this paper, a methodology for modelling a dynamic equivalent of an external area is presented. The equivalent consists of a generator with series impedance and a parallel load (generalized Ward equivalent), integrating control systems such as the
Externí odkaz:
http://arxiv.org/abs/2408.06480
Autor:
Rivera Flores IV; RNA Therapeutics Institute, University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA., Monopoli K; RNA Therapeutics Institute, University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA., Jackson S; RNA Therapeutics Institute, University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA., Echeverria D; RNA Therapeutics Institute, University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA., O'Reilly D; RNA Therapeutics Institute, University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA., Brown RH; Department of Neurology, University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA., Khvorova A; RNA Therapeutics Institute, University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA.
Publikováno v:
Nucleic acid therapeutics [Nucleic Acid Ther] 2024 Oct; Vol. 34 (5), pp. 234-244. Date of Electronic Publication: 2024 Aug 27.
Autor:
Montero MM; Infectious Diseases Service, Hospital del Mar, Barcelona, Spain. Infectious Pathology and Antimicrobials Research Group (IPAR), Hospital del Mar Research Institute (IMIM), Barcelona, Spain.; Department of Medicine and Life Sciences (MELIS), Universitat Pompeu Fabra Barcelona, Barcelona, Spain.; CIBER of Infectious Diseases (CIBERINFEC CB21/13/00002 and CB21/13/00099), Institute of Health Carlos III, Madrid, Spain., Domene-Ochoa S; Infectious Diseases Service, Hospital del Mar, Barcelona, Spain. Infectious Pathology and Antimicrobials Research Group (IPAR), Hospital del Mar Research Institute (IMIM), Barcelona, Spain., Prim N; MicrobiologyService, Laboratori de Referència de Catalunya, Barcelona, Spain., Ferola E; Infectious Diseases Service, Hospital del Mar, Barcelona, Spain. Infectious Pathology and Antimicrobials Research Group (IPAR), Hospital del Mar Research Institute (IMIM), Barcelona, Spain., López-Causapé C; Servicio de Microbiología y Unidad de Investigación, Hospital Son Espases, IdISBa, Palma de Mallorca, Spain., Echeverria D; PharmacyService, Hospital del Mar, Barcelona, Spain., Morisaki MFA; Microbiology service, Hospital Universitario Ramon y Cajal, Madrid, Spain., Vega-Toribio V; MicrobiologyService, Laboratori de Referència de Catalunya, Barcelona, Spain., Sorlí L; Infectious Diseases Service, Hospital del Mar, Barcelona, Spain. Infectious Pathology and Antimicrobials Research Group (IPAR), Hospital del Mar Research Institute (IMIM), Barcelona, Spain.; Department of Medicine and Life Sciences (MELIS), Universitat Pompeu Fabra Barcelona, Barcelona, Spain.; CIBER of Infectious Diseases (CIBERINFEC CB21/13/00002 and CB21/13/00099), Institute of Health Carlos III, Madrid, Spain., Luque S; CIBER of Infectious Diseases (CIBERINFEC CB21/13/00002 and CB21/13/00099), Institute of Health Carlos III, Madrid, Spain.; PharmacyService, Hospital del Mar, Barcelona, Spain., Padilla E; MicrobiologyService, Laboratori de Referència de Catalunya, Barcelona, Spain., Oliver A; CIBER of Infectious Diseases (CIBERINFEC CB21/13/00002 and CB21/13/00099), Institute of Health Carlos III, Madrid, Spain.; Servicio de Microbiología y Unidad de Investigación, Hospital Son Espases, IdISBa, Palma de Mallorca, Spain., Horcajada JP; Infectious Diseases Service, Hospital del Mar, Barcelona, Spain. Infectious Pathology and Antimicrobials Research Group (IPAR), Hospital del Mar Research Institute (IMIM), Barcelona, Spain.; Department of Medicine and Life Sciences (MELIS), Universitat Pompeu Fabra Barcelona, Barcelona, Spain.; CIBER of Infectious Diseases (CIBERINFEC CB21/13/00002 and CB21/13/00099), Institute of Health Carlos III, Madrid, Spain.
Publikováno v:
Infectious diseases (London, England) [Infect Dis (Lond)] 2024 Aug 30, pp. 1-8. Date of Electronic Publication: 2024 Aug 30.
Autor:
Susorov D; RNA Therapeutics Institute, UMass Chan Medical School, 368 Plantation Street, Worcester, MA 01605, USA., Echeverria D; RNA Therapeutics Institute, UMass Chan Medical School, 368 Plantation Street, Worcester, MA 01605, USA., Khvorova A; RNA Therapeutics Institute, UMass Chan Medical School, 368 Plantation Street, Worcester, MA 01605, USA., Korostelev AA; RNA Therapeutics Institute, UMass Chan Medical School, 368 Plantation Street, Worcester, MA 01605, USA.
Publikováno v:
Nucleic acids research [Nucleic Acids Res] 2024 Aug 27; Vol. 52 (15), pp. 8687-8701.
Autor:
Yamada K; RNA Therapeutics Institute, University of Massachusetts Chan Medical School, Worcester, MA, USA. ken.yamada@umassmed.edu., Hariharan VN; RNA Therapeutics Institute, University of Massachusetts Chan Medical School, Worcester, MA, USA., Caiazzi J; RNA Therapeutics Institute, University of Massachusetts Chan Medical School, Worcester, MA, USA., Miller R; RNA Therapeutics Institute, University of Massachusetts Chan Medical School, Worcester, MA, USA.; Department of Medicine, University of Massachusetts Chan Medical School, Worcester, MA, USA., Ferguson CM; RNA Therapeutics Institute, University of Massachusetts Chan Medical School, Worcester, MA, USA.; Department of Medicine, University of Massachusetts Chan Medical School, Worcester, MA, USA., Sapp E; Department of Neurology, Harvard Medical School and Mass General Institute for Neurodegenerative Disease, Charlestown, MA, USA., Fakih HH; RNA Therapeutics Institute, University of Massachusetts Chan Medical School, Worcester, MA, USA., Tang Q; RNA Therapeutics Institute, University of Massachusetts Chan Medical School, Worcester, MA, USA., Yamada N; RNA Therapeutics Institute, University of Massachusetts Chan Medical School, Worcester, MA, USA., Furgal RC; RNA Therapeutics Institute, University of Massachusetts Chan Medical School, Worcester, MA, USA., Paquette JD; RNA Therapeutics Institute, University of Massachusetts Chan Medical School, Worcester, MA, USA.; Department of Medicine, University of Massachusetts Chan Medical School, Worcester, MA, USA., Biscans A; RNA Therapeutics Institute, University of Massachusetts Chan Medical School, Worcester, MA, USA., Bramato BM; RNA Therapeutics Institute, University of Massachusetts Chan Medical School, Worcester, MA, USA., McHugh N; RNA Therapeutics Institute, University of Massachusetts Chan Medical School, Worcester, MA, USA., Summers A; RNA Therapeutics Institute, University of Massachusetts Chan Medical School, Worcester, MA, USA., Lochmann C; RNA Therapeutics Institute, University of Massachusetts Chan Medical School, Worcester, MA, USA., Godinho BMDC; RNA Therapeutics Institute, University of Massachusetts Chan Medical School, Worcester, MA, USA., Hildebrand S; RNA Therapeutics Institute, University of Massachusetts Chan Medical School, Worcester, MA, USA., Jackson SO, Echeverria D; RNA Therapeutics Institute, University of Massachusetts Chan Medical School, Worcester, MA, USA., Hassler MR; RNA Therapeutics Institute, University of Massachusetts Chan Medical School, Worcester, MA, USA., Alterman JF; RNA Therapeutics Institute, University of Massachusetts Chan Medical School, Worcester, MA, USA., DiFiglia M; Department of Neurology, Harvard Medical School and Mass General Institute for Neurodegenerative Disease, Charlestown, MA, USA., Aronin N; RNA Therapeutics Institute, University of Massachusetts Chan Medical School, Worcester, MA, USA.; Department of Medicine, University of Massachusetts Chan Medical School, Worcester, MA, USA., Khvorova A; RNA Therapeutics Institute, University of Massachusetts Chan Medical School, Worcester, MA, USA. anastasia.khvorova@umassmed.edu.; Program in Molecular Medicine, University of Massachusetts Chan Medical School, Worcester, MA, USA. anastasia.khvorova@umassmed.edu.
Publikováno v:
Nature biotechnology [Nat Biotechnol] 2024 Aug 01. Date of Electronic Publication: 2024 Aug 01.
Autor:
Gilbert JW; RNA Therapeutic Institute, Worcester, MA 01655, USA., Kennedy Z; RNA Therapeutic Institute, Worcester, MA 01655, USA., Godinho BMDC; RNA Therapeutic Institute, Worcester, MA 01655, USA., Summers A; RNA Therapeutic Institute, Worcester, MA 01655, USA., Weiss A; Department of Neurology, University of Massachusetts Chan Medical School, Worcester, MA 01655, USA., Echeverria D; RNA Therapeutic Institute, Worcester, MA 01655, USA., Bramato B; RNA Therapeutic Institute, Worcester, MA 01655, USA., McHugh N; RNA Therapeutic Institute, Worcester, MA 01655, USA., Cooper D; RNA Therapeutic Institute, Worcester, MA 01655, USA., Yamada K; RNA Therapeutic Institute, Worcester, MA 01655, USA., Hassler M; RNA Therapeutic Institute, Worcester, MA 01655, USA., Tran H; Department of Neurology, University of Massachusetts Chan Medical School, Worcester, MA 01655, USA., Gao FB; RNA Therapeutic Institute, Worcester, MA 01655, USA., Brown RH Jr; Department of Neurology, University of Massachusetts Chan Medical School, Worcester, MA 01655, USA., Khvorova A; RNA Therapeutic Institute, Worcester, MA 01655, USA.
Publikováno v:
Molecular therapy. Nucleic acids [Mol Ther Nucleic Acids] 2024 Jul 31; Vol. 35 (3), pp. 102291. Date of Electronic Publication: 2024 Jul 31 (Print Publication: 2024).
Autor:
Weiss A; Department of Neurology, UMass Chan Medical School; Worcester, MA, USA., Gilbert JW; RNA Therapeutics Institute, UMass Chan Medical School; Worcester, MA, USA., Flores IVR; RNA Therapeutics Institute, UMass Chan Medical School; Worcester, MA, USA., Belgrad J; RNA Therapeutics Institute, UMass Chan Medical School; Worcester, MA, USA., Ferguson C; RNA Therapeutics Institute, UMass Chan Medical School; Worcester, MA, USA., Dogan EO; Department of Neurology, UMass Chan Medical School; Worcester, MA, USA., Wightman N; Department of Neurology, UMass Chan Medical School; Worcester, MA, USA., Mocarski K; Department of Neurology, UMass Chan Medical School; Worcester, MA, USA.; Program in Molecular Medicine, UMass Chan Medical School; Worcester, MA, USA., Echeverria D; RNA Therapeutics Institute, UMass Chan Medical School; Worcester, MA, USA., Summers A; RNA Therapeutics Institute, UMass Chan Medical School; Worcester, MA, USA., Bramato B; RNA Therapeutics Institute, UMass Chan Medical School; Worcester, MA, USA., McHugh N; RNA Therapeutics Institute, UMass Chan Medical School; Worcester, MA, USA., Furgal R; RNA Therapeutics Institute, UMass Chan Medical School; Worcester, MA, USA., Yamada N; RNA Therapeutics Institute, UMass Chan Medical School; Worcester, MA, USA., Cooper D; RNA Therapeutics Institute, UMass Chan Medical School; Worcester, MA, USA., Monopoli K; RNA Therapeutics Institute, UMass Chan Medical School; Worcester, MA, USA., Godinho BMDC; RNA Therapeutics Institute, UMass Chan Medical School; Worcester, MA, USA., Hassler MR; RNA Therapeutics Institute, UMass Chan Medical School; Worcester, MA, USA., Yamada K; RNA Therapeutics Institute, UMass Chan Medical School; Worcester, MA, USA., Greer P; Program in Molecular Medicine, UMass Chan Medical School; Worcester, MA, USA., Henninger N; Department of Neurology, UMass Chan Medical School; Worcester, MA, USA.; Department of Psychiatry, UMass Chan Medical School; Worcester, MA, USA., Brown RH Jr; Department of Neurology, UMass Chan Medical School; Worcester, MA, USA., Khvorova A; RNA Therapeutics Institute, UMass Chan Medical School; Worcester, MA, USA.; Program in Molecular Medicine, UMass Chan Medical School; Worcester, MA, USA.
Publikováno v:
BioRxiv : the preprint server for biology [bioRxiv] 2024 Jun 25. Date of Electronic Publication: 2024 Jun 25.
Autor:
Belgrad J; RNA Therapeutics Institute, University of Massachusetts Chan Medical School; Worcester, MA, USA., Tang Q; RNA Therapeutics Institute, University of Massachusetts Chan Medical School; Worcester, MA, USA., Hildebrand S; RNA Therapeutics Institute, University of Massachusetts Chan Medical School; Worcester, MA, USA., Summers A; RNA Therapeutics Institute, University of Massachusetts Chan Medical School; Worcester, MA, USA., Sapp E; Department of Neurology, Massachusetts General Hospital; Charlestown, MA, USA., Echeverria D; RNA Therapeutics Institute, University of Massachusetts Chan Medical School; Worcester, MA, USA., O'Reilly D; RNA Therapeutics Institute, University of Massachusetts Chan Medical School; Worcester, MA, USA., Luu E; RNA Therapeutics Institute, University of Massachusetts Chan Medical School; Worcester, MA, USA., Bramato B; RNA Therapeutics Institute, University of Massachusetts Chan Medical School; Worcester, MA, USA., Allen S; RNA Therapeutics Institute, University of Massachusetts Chan Medical School; Worcester, MA, USA., Cooper D; RNA Therapeutics Institute, University of Massachusetts Chan Medical School; Worcester, MA, USA., Alterman J; RNA Therapeutics Institute, University of Massachusetts Chan Medical School; Worcester, MA, USA., Yamada K; RNA Therapeutics Institute, University of Massachusetts Chan Medical School; Worcester, MA, USA., Aronin N; RNA Therapeutics Institute, University of Massachusetts Chan Medical School; Worcester, MA, USA.; Department of Medicine, University of Massachusetts Chan Medical School; Worcester, MA, USA., DiFiglia M; Department of Neurology, Massachusetts General Hospital; Charlestown, MA, USA., Khvorova A; RNA Therapeutics Institute, University of Massachusetts Chan Medical School; Worcester, MA, USA.; Program in Molecular Medicine, University of Massachusetts Chan Medical School; Worcester, MA, USA.
Publikováno v:
Nucleic acids research [Nucleic Acids Res] 2024 Jun 24; Vol. 52 (11), pp. 6099-6113.
Autor:
Sarli SL; RNA Therapeutics Institute, University of Massachusetts Chan Medical School, Worcester, MA, USA., Fakih HH; RNA Therapeutics Institute, University of Massachusetts Chan Medical School, Worcester, MA, USA., Kelly K; RNA Therapeutics Institute, University of Massachusetts Chan Medical School, Worcester, MA, USA., Devi G; RNA Therapeutics Institute, University of Massachusetts Chan Medical School, Worcester, MA, USA., Rembetsy-Brown JM; RNA Therapeutics Institute, University of Massachusetts Chan Medical School, Worcester, MA, USA., McEachern HR; RNA Therapeutics Institute, University of Massachusetts Chan Medical School, Worcester, MA, USA., Ferguson CM; RNA Therapeutics Institute, University of Massachusetts Chan Medical School, Worcester, MA, USA., Echeverria D; RNA Therapeutics Institute, University of Massachusetts Chan Medical School, Worcester, MA, USA., Lee J; RNA Therapeutics Institute, University of Massachusetts Chan Medical School, Worcester, MA, USA., Sousa J; RNA Therapeutics Institute, University of Massachusetts Chan Medical School, Worcester, MA, USA., Sleiman HF; Department of Chemistry, McGill University, Montréal, Québec, Canada., Khvorova A; RNA Therapeutics Institute, University of Massachusetts Chan Medical School, Worcester, MA, USA.; Program in Molecular Medicine, University of Massachusetts Chan Medical School, Worcester, MA, USA., Watts JK; RNA Therapeutics Institute, University of Massachusetts Chan Medical School, Worcester, MA, USA.; Department of Biochemistry and Molecular Biotechnology, University of Massachusetts Chan Medical School, Worcester, MA, USA.
Publikováno v:
Nucleic acids research [Nucleic Acids Res] 2024 May 22; Vol. 52 (9), pp. 4799-4817.
Autor:
Ferguson CM; RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA, 01605, USA., Godinho BMDC; RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA, 01605, USA., Echeverria D; RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA, 01605, USA., Hassler M; RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA, 01605, USA., Vangjeli L; RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA, 01605, USA., Sousa J; RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA, 01605, USA., McHugh N; RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA, 01605, USA., Alterman J; RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA, 01605, USA., Hariharan V; RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA, 01605, USA., Krishnamurthy PM; RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA, 01605, USA., Watts J; RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA, 01605, USA., Rogaev E; Department of Psychiatry, University of Massachusetts Medical School, Worcester, MA, 01605, USA., Khvorova A; RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA, 01605, USA.; Department of Medicine, University of Massachusetts Medical School, Worcester, MA, 01605, USA.
Publikováno v:
Nucleic acids research [Nucleic Acids Res] 2024 May 22; Vol. 52 (9), pp. 5273-5284.